Mississippi medical board advertising rules: the MSBML Chapter 12 guide

MSBML Rule 12.3, requirement by requirement

Rule 12.2 defines advertising broadly: office signage, print, directories, radio, television, direct mail, billboards, "computer", business cards, billing statements, letterhead and "any other means" of communicating with the public or patients. Websites, search ads and social posts fall inside it.

Rule 12.3(A) says an ad may include education or specialty, how fees are set (including charges for specific services), credit and payment methods, and "any other non-deceptive information". Rule 12.3(B) to (D) set the general standard: no omission of necessary information, no false or misleading statement, nothing that otherwise deceives, plain language rather than hard medical terms, and nothing that creates "unjustified medical expectations".

The 13 specific requirements in Rule 12.3(E)

1. Every ad and written communication names at least one physician responsible for its content. For office signage, a sign near the main entrance names that physician.
2. Physicians are identified as M.D., D.O. or D.P.M., not only "Doctor" or "Dr."
3. An advertised fee for a service is honored for at least 90 days, unless the ad states a longer period. For media published once a year or less often, honor it for one year.
4. No merely self-laudatory statements and no statements characterizing the quality of the physician's services.
5. "Board Certified" only with full disclosure of the certifying board, and only with proof of current certification by an ABMS or AOA recognized board.
6. "Specialist" only after an ACGME, AOA or APMA recognized residency (with proof), or with proof of grandfathering through ABMS or AOA board certification.
7. No comparison with other physicians unless it can be factually substantiated. The rule names "the best", "one of the best" and "one of the most experienced" as examples of what this precludes.
8. Testimonials need a clear and prominent disclosure of (a) the generally expected outcome and (b) the limited applicability of the endorser's experience.
9. Claims of success, efficacy or result (for example "cure") need scientific evidence.
10. "Typical" result claims must be based on a sample of all patients who entered the program (or of the subset the claim refers to).
11. Any claim about the safety of a procedure or drug must also disclose the risk of adverse complications.
12. No claim that a drug treats a condition unless it has an FDA-approved indication for that purpose.
13. Any claim that surgery achieves improvement in a set time must also state the typical recovery time.

Rule 12.3(F) adds that, consistent with federal standards, the physician must have a reasonable basis for claims before the ad runs. Rule 12.3(G) clarifies that directory, HMO and preferred-provider listings used mainly for referrals are not restricted.

What is different about Mississippi

Alternative and regenerative therapy advertising (Rule 13.9)

Mississippi has a separate chapter for complementary, alternative and regenerative medicine (Chapter 13). It names IV infusion and hydration therapy, stem cell therapy and the use of artificial intelligence as examples. Rule 13.9 says information in advertising, "including but not limited to clinic websites and social media", must be accurate and come from reputable peer-reviewed publications or respected external organizations. It lists practices the Board treats as deceptive, such as claiming certification by international standards bodies to legitimize a therapy, convening advisory boards of prominent people for the same purpose, registering trials that mainly recruit paying patients, and using the impression of "ethics review" as a selling point. Wellness and IV bars run by physicians should read Rule 13.9 alongside Chapter 12.

Physician assistants and transparency

PAs may not advertise in a way that implies they practice independently (Rule 1.10). PAs working in an off-site or satellite office without the supervising physician on site must post the supervising physician's name, credentials and contact information in the waiting room, which the rule ties to Miss. Code Ann. 41-121-1 et seq.

Telemedicine

Chapter 5 of the same rules covers telemedicine, defined as practice using HIPAA-compliant telecommunication systems that can replicate an in-person encounter. A telehealth practice marketing to Mississippi patients needs a Mississippi license (or an exception) and its ads are still subject to Chapter 12, including the M.D./D.O. naming and responsible-physician requirements.

Penalty route

Under Rule 12.4, breaking the advertising rule is unprofessional conduct, "dishonorable or unethical conduct likely to deceive, defraud or harm the public", under Miss. Code Ann. 73-25-29(8)(d) and 73-27-13(h)(iv). That is a licensing matter, separate from any consumer claim under state consumer-protection law.